Drugmaker Avanir Pays $116 Million in Fraud Settlement After Pushing Medication on Dementia Patients
By
Phil Gutis
| October 1st, 2019
A drugmaker agreed to pay $116 million in penalties to settle charges by the U.S. government that it sought to improperly influence doctors in…